(HealthDay)—For patients with refractory or relapsed peripheral T-cell lymphoma (R/R-PTCL), three- and five-year overall survival (OS) and progression-free survival (PFS) are similar with allogeneic or autologous […]
The antibodies we create after we’re infected with a virus or vaccinated against it can be very powerful. A virus typically spreads within our bodies by […]
Researchers from the Brain Research Institute, Niigata University, Japan may have unraveled a new approach that could revolutionize the treatment, prevention, and possibly reversal of the […]